{"id":5640,"date":"2017-02-28T20:55:45","date_gmt":"2017-03-01T01:55:45","guid":{"rendered":"http:\/\/localhost:10028\/practiceareas\/plavix-lawsuit-attorneys\/"},"modified":"2022-06-21T16:53:58","modified_gmt":"2022-06-21T20:53:58","slug":"plavix-dava-avukatlari","status":"publish","type":"practiceareas","link":"https:\/\/napolilaw.lemonadestand.org\/tr\/uygulama-alanlari-2\/plavix-dava-avukatlari\/","title":{"rendered":"Plavix"},"content":{"rendered":"<h2 class=\"update-highlight\" style=\"text-align: center; background-color: red;\">ARTIK PLAVIX VAKALARINI KABUL ETM\u0130YORUZ<\/h2>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-6076 size-large\" src=\"https:\/\/www.napolilaw.lemonadestand.org\/wp-content\/uploads\/2022\/06\/doctor-with-prescription-1024x256-1.jpg\" alt=\"Re\u00e7eteli Plavix dava doktoru\" width=\"900\" height=\"225\" \/><\/p>\n<h2>PLAVIX DAVA avukatlar\u0131<\/h2>\n<p>Plavix\u00ae is taken to reduce the risk of heart attack or stroke. The anticoagulant medication, active ingredient clopidogrel, is recommended for patients who have recently suffered a heart attack or stroke, as well as those with certain heart or blood vessel conditions. Napoli Shkolnik a national law firm specializing in Pharmaceutical Claims of bad drugs.<\/p>\n<p>Manufactured by Bristol-Myers Squibb, Plavix\u00ae, especially when taken with other blood thinning medications, can increase a patient\u2019s likelihood of sustaining severe harm and death.<\/p>\n<h2>Plavix Avukatlar\u0131<\/h2>\n<p>Son birka\u00e7 y\u0131lda Plavix&#039;in olumsuz etkileri hakk\u0131nda bir\u00e7ok hikaye, dava ve ara\u015ft\u0131rma yap\u0131ld\u0131. Bilimsel \u00e7evrelerde yayg\u0131n olarak klopidogrel bis\u00fclfat olarak bilinen Plavix, genellikle belirli kardiyovask\u00fcler ve kan damar\u0131 bozukluklar\u0131 olan ki\u015filere re\u00e7ete edilen bir ila\u00e7t\u0131r. Ancak ilac\u0131n ya\u015fam\u0131 tehdit eden riskleri, bu kan suland\u0131r\u0131c\u0131 tedavi nedeniyle ciddi yaralanmalar ya\u015fayan say\u0131s\u0131z Plavix ma\u011fdurunun Plavix davas\u0131na kat\u0131lmas\u0131na neden oldu.<\/p>\n<h2>Plavix Men\u015fei ve Kullan\u0131m\u0131<\/h2>\n<p>bunu biliyor muydun <a href=\"https:\/\/www.cdc.gov\/heartdisease\/facts.htm\" target=\"_blank\" rel=\"noopener\">735.000 Amerikal\u0131 kalp krizi ge\u00e7iriyor<\/a> every year? And, the number continues to rise if we take into account other injuries to the heart, also known as cardiac events.<\/p>\n<p>Amerika Birle\u015fik Devletleri&#039;ndeki milyonlarca insan, genellikle \u00f6l\u00fcmc\u00fcl bir sonucu olan kalp hastal\u0131\u011f\u0131 ve kalp yaralanmalar\u0131ndan muzdariptir. Gelecekte ba\u015fka bir kardiyak olay\u0131 \u00f6nlemek i\u00e7in, hastalara daha fazla kalp problemi riskini en aza indirgemek i\u00e7in uygun t\u0131bbi tedaviler re\u00e7ete edilir ve en yayg\u0131n re\u00e7ete edilen \u00e7\u00f6z\u00fcmlerden biri de Plavix olarak bilinen bir ila\u00e7t\u0131r.<\/p>\n<p>\u0130lk kez 1997&#039;de FDA taraf\u0131ndan onayland\u0131\u011f\u0131ndan beri Plavix, fel\u00e7 veya kalp krizi gibi kardiyovask\u00fcler sorun riski y\u00fcksek olan ki\u015filere d\u00fczenli olarak re\u00e7ete edildi. Bristol-Myers Squibb ilac\u0131 k\u0131sa s\u00fcrede piyasada en \u00e7ok satan ila\u00e7 haline geldi ve on y\u0131ll\u0131k pop\u00fclaritesinde yakla\u015f\u0131k $7 milyar sat\u0131\u015f yapt\u0131.<\/p>\n<p>Nevertheless, the good luck of Plavix eventually ran out and its sales dropped in 2012 after evidence showed that the drug caused a variety of health problems for thousands of its users. Approximately 2,000 injured parties gathered in the Plavix lawsuit, some of which had suffered from heavy internal bleeding and others from severe bleeding after an ordinary cut.<\/p>\n<p>To make the matter worse, a number of plaintiffs had sustained significant brain injuries or died during the Plavix treatment.<\/p>\n<p>The greatest danger of taking Plavix is the risk of severe bleeding. According to the\u00a0U.S. Food and Drug Administration\u2019s medication <a href=\"http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM243349.pdf\" target=\"_blank\" rel=\"noopener\">Plavix i\u00e7in rehber.<br \/>\n<\/a><\/p>\n<blockquote><p>Plavix ciddi olabilen kanamalara neden olabilir ve bazen <strong>\u00f6l\u00fcme yol a\u00e7mak<\/strong>.<\/p><\/blockquote>\n<p>Sadece kanamaya ek olarak, Plavix ayr\u0131ca \u015funlarla da ili\u015fkilendirilmi\u015ftir:<\/p>\n<p style=\"padding-left: 30px;\">\u25cf beyin kanamas\u0131<\/p>\n<p style=\"padding-left: 30px;\">\u25cf Gastrointestinal kanama<\/p>\n<p style=\"padding-left: 30px;\">\u25cf \u0130\u00e7 kanama<\/p>\n<p style=\"padding-left: 30px;\">\u25cf Kemik \u0130li\u011fi Hasar\u0131<\/p>\n<p style=\"padding-left: 30px;\">\u25cf Tekrarlayan \u00fclserler<\/p>\n<p style=\"padding-left: 30px;\">\u25cf Kalp krizi<\/p>\n<p style=\"padding-left: 30px;\">\u25cf Vuru\u015flar<\/p>\n<p style=\"padding-left: 30px;\">\u25cf Trombotik Trombositopenik Purpura (TTP)<\/p>\n<p style=\"padding-left: 30px;\">\u25cf \u00d6l\u00fcm<\/p>\n<p>&nbsp;<\/p>\n<h2>KUSURLU B\u0130R \u0130LA\u00c7 HASTAYA ZARAR VERD\u0130\u011e\u0130NDE<\/h2>\n<p>Bir hastan\u0131n sa\u011fl\u0131\u011f\u0131n\u0131 ve ya\u015fam kalitesini iyile\u015ftirmek i\u00e7in al\u0131nan ila\u00e7lar tam da bunu yapmal\u0131d\u0131r; Bir ila\u00e7 kusurlu oldu\u011funda, bir hastay\u0131 gereksiz yere zarar g\u00f6rme ve ciddi sa\u011fl\u0131k komplikasyonlar\u0131 riskine sokarsa, birinin sorumlu tutulmas\u0131 gerekir. Plavix kusurlu bir \u015fekilde tasarland\u0131\u011f\u0131ndan ve bir hasta i\u00e7in yarardan \u00e7ok risk ta\u015f\u0131yabilece\u011finden, Bristol-Myers Squibb zararlardan sorumlu tutulabilir.<\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-6077 size-large\" src=\"https:\/\/www.napolilaw.lemonadestand.org\/wp-content\/uploads\/2022\/06\/lawsuit-image-1024x680-1.jpg\" alt=\"Plavix davas\u0131 sunan adam \" width=\"900\" height=\"598\" \/><\/p>\n<p>&nbsp;<\/p>\n<h2>PLAVIX KASA HAKKINDA<\/h2>\n<p>The safety of Plavix has been questioned for a while now. In fact, The New England Journal of Medicine published a study in 2005 that confirmed that users of Plavix have a higher rate of developing ulcers, internal bleeding, hemorrhages, strokes, and other serious conditions than patients who took other forms of medication.<\/p>\n<p>The following year, another study startled the community as the journal proved once again that Plavix combined with aspirin offered no additional benefits to taking aspirin alone. These findings encouraged FDA\u2019s warning in 2009 and 2010, stating that Plavix may have a reduced effectiveness for certain patients.<\/p>\n<p>All of these claims began to unravel when Hawaii officials filed a suit against Bristol-Myers and their Sanofi partners in 2014. In the lawsuit, the plaintiffs claimed both companies failed to disclose the lack of Plavix\u2019s effectiveness on 30% of the population, as well as the risks of gastrointestinal bleeding.<\/p>\n<p>This course of action inspired the chain of lawsuits, once the New Jersey federal judge reinstated a Plavix whistleblower lawsuit after U.S. Supreme Court ruled that there is a basis for liability in such cases.<\/p>\n<h2>Plavix Davas\u0131 Yan Etkileri<\/h2>\n<p>Plavix, kar\u0131n a\u011fr\u0131s\u0131, g\u00f6\u011f\u00fcs a\u011fr\u0131s\u0131, zat\u00fcrree, d\u00fczensiz kalp at\u0131\u015f\u0131, ba\u015f a\u011fr\u0131s\u0131 ve iltihaplanma gibi zararl\u0131 yan etkilerle ili\u015fkilendirilmi\u015ftir. Bununla birlikte, Plavix&#039;in en u\u011fursuz etkileri \u015funlard\u0131r:<\/p>\n<p style=\"padding-left: 30px;\">\u25cf beyin kanamas\u0131<\/p>\n<p style=\"padding-left: 30px;\">\u25cf Gastrointestinal kanama<\/p>\n<p style=\"padding-left: 30px;\">\u25cf \u0130\u00e7 kanama<\/p>\n<p style=\"padding-left: 30px;\">\u25cf Kemik \u0130li\u011fi Hasar\u0131<\/p>\n<p style=\"padding-left: 30px;\">\u25cf Tekrarlayan \u00fclserler<\/p>\n<p style=\"padding-left: 30px;\">\u25cf Kalp krizi<\/p>\n<p style=\"padding-left: 30px;\">\u25cf Vuru\u015flar<\/p>\n<p style=\"padding-left: 30px;\">\u25cf Trombotik Trombositopenik Purpura (TTP)<\/p>\n<p style=\"padding-left: 30px;\">\u25cf \u00d6l\u00fcm<\/p>\n<h2>Plavix Dava G\u00fcncellemesi<\/h2>\n<p>This June, the Supreme Court of California made a final ruling and stated that California Supreme Court doesn\u2019t have the jurisdiction to oversee a case involving out-of-state plaintiffs. In other words, 575 of Plavix victims are left wondering what this means for their cases.<\/p>\n<p>But the only hope to finally put a stop to Plavix is by joining forces as the Supreme Court opinion closes by offering specific options in which legislation could proceed in spite of the court\u2019s decision:<\/p>\n<p>\u201cOur decision does not prevent the California and other out-of-state plaintiffs from joining together in a consolidated action in the States that have general jurisdiction over BMS. \u2026. Alternatively, the plaintiffs who are residents of a particular State\u2014for example, the 92 plaintiffs from Texas and the 71 from Ohio\u2014could probably sue together in their home States. In addition, since our decision concerns the due process limits on the exercise of specific jurisdiction by a State, we leave open the question whether the Fifth Amendment imposes the same restrictions on the exercise of personal jurisdiction by a federal court.\u201d<\/p>\n<h2 class=\"update-highlight\" style=\"text-align: center; background-color: red;\">ARTIK PLAVIX VAKALARINI KABUL ETM\u0130YORUZ<\/h2>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>ARTIK PLAVIX VAKALARINI KABUL ETM\u0130YORUZ PLAVIX DAVASI avukatlar Plavix\u00ae kalp krizi veya inme riskini azaltmak i\u00e7in al\u0131n\u0131yor. Antikoag\u00fclan ila\u00e7, aktif madde klopidogrel tavsiye edilir\u2026<\/p>","protected":false},"featured_media":5644,"menu_order":184,"template":"","practiceareas_category":[743],"class_list":["post-5640","practiceareas","type-practiceareas","status-publish","has-post-thumbnail","hentry","practiceareas_category-pharmaceutical-litigation"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas\/5640","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/types\/practiceareas"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas\/5640\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media\/5644"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media?parent=5640"}],"wp:term":[{"taxonomy":"practiceareas_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas_category?post=5640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}